Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Clinical trial NCT00483652 · COMPLETED

Trial details

NCT number: NCT00483652
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-05-01
Primary completion: 2008-02-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.